What is the share price of CSL Limited?

CSL Limited The share price at the dates of exercise (expressed as a weighted average) by equity instrument type, is as follows: 2019 2018 Options A$215.88

What products does CSL Ltd offer?

The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins. Stock analysis for CSL Ltd (CSL:ASE) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Who is CSL Limited?

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments.